Its announcement arrives around the heels of an identical licensing arrangement provided in February to Adastra Labs, which experienced right until now centered on crafting cannabis extracts. Adastra's license also makes it possible for it to create and market psilocybin and psilocin – hallucinogens more commonly generally known as magic mushroom